Word

SURMOUNT BIO

Status

Dead

Status Code

606

Status Date

Monday, January 16, 2023

Serial Number

88521089

Mark Type

4000

Filing Date

Thursday, July 18, 2019

Published for Opposition

Tuesday, October 15, 2019

Abandoned Date

Monday, January 16, 2023

Trademark Owner History

ElevateBio, LLC - Owner At Publication

Classifications

5 Gene therapy products, namely, genetically engineered tissues for transplant purposes; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, antivirals; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Anti-cancer preparations; Biological preparations for the treatment of cancer; Digestives for pharmaceutical purposes; Drug delivery agents in the form of a capsule, pill, or liquid that facilitate the delivery of pharmaceutical preparations; Medical preparations for the treatment of cancer, cystic fibrosis, heart disease, and AIDS; Medicinal infusions for treating Cancer, cystic fibrosis, heart disease, and AIDS; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Mixed biological preparations for the prevention and treatment of infectious diseases; Pharmaceutical preparations for the treatment and prevention of Cancer, cystic fibrosis, heart disease, and AIDS; Pharmaceutical products for the prevention and treatment of cancer; Radioactive pharmaceutical preparations for use in vivo diagnostic or therapeutic use; Specialized tablets, capsules and powders for the delivery of pharmaceuticals sold without the pharmaceutical ingredient; Therapeutic pharmaceutical for the treatment of Cancer, cystic fibrosis, heart disease, and AIDS; Unit dose capsules sold empty for pharmaceutical use

"BIO"

Trademark Events

Jan 17, 2023

Abandonment Notice E-Mailed - No Use Statement Filed

Jan 16, 2023

Abandonment - No Use Statement Filed

May 20, 2022

Notice Of Approval Of Extension Request E-Mailed

May 19, 2022

Sou Extension 5 Granted

May 17, 2022

Sou Extension 5 Filed

May 17, 2022

Sou Teas Extension Received

Nov 26, 2021

Notice Of Approval Of Extension Request E-Mailed

Nov 24, 2021

Sou Extension 4 Granted

Nov 24, 2021

Sou Extension 4 Filed

Nov 24, 2021

Sou Teas Extension Received

Nov 18, 2021

Teas Change Of Correspondence Received

Nov 18, 2021

Teas Withdrawal Of Attorney Received-Firm Retains

Nov 18, 2021

Attorney/Dom.Rep.Revoked And/Or Appointed

Nov 18, 2021

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Jun 12, 2021

Notice Of Approval Of Extension Request E-Mailed

Jun 10, 2021

Sou Extension 3 Granted

Jun 10, 2021

Sou Extension 3 Filed

Jun 10, 2021

Sou Teas Extension Received

Jun 10, 2021

Teas Change Of Correspondence Received

Jun 10, 2021

Attorney/Dom.Rep.Revoked And/Or Appointed

Jun 10, 2021

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Jan 23, 2021

Notice Of Approval Of Extension Request E-Mailed

Jan 22, 2021

Sou Extension 2 Granted

Dec 10, 2020

Sou Extension 2 Filed

Jan 12, 2021

Notice Of Revival - E-Mailed

Jan 11, 2021

Sou Extension Received With Teas Petition

Jan 11, 2021

Petition To Revive-Granted

Jan 11, 2021

Teas Petition To Revive Received

Jan 11, 2021

Abandonment Notice E-Mailed - No Use Statement Filed

Jan 11, 2021

Abandonment - No Use Statement Filed

Sep 10, 2020

Notice Of Approval Of Extension Request E-Mailed

Sep 9, 2020

Sou Extension 1 Granted

Jun 10, 2020

Sou Extension 1 Filed

Sep 2, 2020

Case Assigned To Intent To Use Paralegal

Jul 14, 2020

Notice Of Revival - E-Mailed

Jul 14, 2020

Sou Extension Received With Teas Petition

Jul 14, 2020

Petition To Revive-Granted

Jul 14, 2020

Teas Petition To Revive Received

Jul 13, 2020

Abandonment Notice E-Mailed - No Use Statement Filed

Jul 13, 2020

Abandonment - No Use Statement Filed

Dec 10, 2019

Noa E-Mailed - Sou Required From Applicant

Oct 15, 2019

Official Gazette Publication Confirmation E-Mailed

Oct 15, 2019

Published For Opposition

Sep 25, 2019

Notification Of Notice Of Publication E-Mailed

Sep 9, 2019

Assigned To Lie

Sep 5, 2019

Approved For Pub - Principal Register

Sep 3, 2019

Teas/Email Correspondence Entered

Sep 2, 2019

Correspondence Received In Law Office

Sep 2, 2019

Teas Response To Office Action Received

Aug 31, 2019

Notification Of Non-Final Action E-Mailed

Aug 31, 2019

Non-Final Action E-Mailed

Aug 31, 2019

Non-Final Action Written

Aug 29, 2019

Assigned To Examiner

Jul 25, 2019

New Application Office Supplied Data Entered

Jul 22, 2019

New Application Entered